Tryptophan 2,3-dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma.
Sumitomo M, Takahara K, Zennami K, Nagakawa T, Maeda Y, Shiogama K, Yamamoto Y, Muto Y, Nukaya T, Takenaka M, Fukaya K, Ichino M, Sasaki H, Saito K, Shiroki R.
Sumitomo M, et al. Among authors: fukaya k.
Cancer Sci. 2021 Mar;112(3):1038-1047. doi: 10.1111/cas.14797. Epub 2021 Jan 25.
Cancer Sci. 2021.
PMID: 33410234
Free PMC article.